Pathogenesis of Clostridium difficile infection.
暂无分享,去创建一个
[1] J. Brazier. The epidemiology and typing of Clostridium difficile. , 1998, The Journal of antimicrobial chemotherapy.
[2] M. O'brien,et al. Differential effects of Clostridium difficile toxins A and B on rabbit ileum. , 1987, Gastroenterology.
[3] E. Rubin,et al. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain , 1988, Infection and immunity.
[4] P. Millard,et al. Clostridium difficile diarrhoea: a highly infectious organism. , 1984, Age and ageing.
[5] J. Bartlett,et al. ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITIS IN CHILDREN , 1981, Pediatrics.
[6] J. Bartlett. Antibiotic associated diarrhea. , 2002, Delaware medical journal.
[7] W. E. Golden,et al. Pseudomembranous colitis. , 1996, The Journal of the Arkansas Medical Society.
[8] S. Finegold,et al. Clostridium difficile : its role in intestinal disease , 1988 .
[9] S. Borriello,et al. Mucosal association by Clostridium difficile in the hamster gastrointestinal tract. , 1988, Journal of medical microbiology.
[10] J. Johnson,et al. The toxigenic element of Clostridium difficile strain VPI 10463. , 1995, Microbial pathogenesis.
[11] S. Borriello,et al. Hydrolytic enzyme production by Clostridium difficile and its relationship to toxin production and virulence in the hamster model. , 1990, Journal of medical microbiology.
[12] J. Ketley,et al. Biological mode of action of Clostridium difficile toxin A: a novel enterotoxin. , 1987, Journal of medical microbiology.
[13] A. Price,et al. Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile , 1992, Infection and immunity.
[14] I. C. Hall,et al. INTESTINAL FLORA IN NEW-BORN INFANTS: WITH A DESCRIPTION OF A NEW PATHOGENIC ANAEROBE, BACILLUS DIFFICILIS , 1935 .
[15] K. Watanabe,et al. Effects of Clostridium difficile toxin A and toxin B on phospholipase D activation in human promyelocytic leukemic HL60 cells , 1996, Infection and immunity.
[16] C. Surawicz,et al. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. , 1990, The Journal of infectious diseases.
[17] K. Wilson,et al. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora , 1988, Infection and immunity.
[18] M. Delmée,et al. Virulence of ten serogroups of Clostridium difficile in hamsters. , 1990, Journal of medical microbiology.
[19] G. Corthier,et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile , 1992, Infection and immunity.
[20] A. Price,et al. Epidemiology of experimental enterocecitis due to Clostridium difficile. , 1980, The Journal of infectious diseases.
[21] T. Wilkins,et al. Clostridium difficile: its disease and toxins , 1988, Clinical Microbiology Reviews.
[22] I. Hill,et al. Epidemiology of Clostridium difficile in infants. , 1982, The Journal of infectious diseases.
[23] M. Mann,et al. Glucosylation of Rho proteins by Clostridium difficile toxin B , 1995, Nature.
[24] C. von Eichel-Streiber,et al. Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. , 1997, FEMS microbiology letters.
[25] K. Aktories,et al. The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. , 1995, The Journal of clinical investigation.
[26] J. Ketley,et al. Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. , 1986, Gut.
[27] P. Sipponen,et al. Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study. , 1981, Scandinavian journal of gastroenterology.
[28] S. Borriello,et al. Virulence factors of Clostridium difficile. , 1990, Reviews of infectious diseases.
[29] J. Ketley,et al. The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits. , 1987, Journal of Medical Microbiology.
[30] S. Borriello,et al. Cell surface properties of Clostridium difficile: haemagglutination, relative hydrophobicity and charge. , 1996, Journal of medical microbiology.
[31] S. Donta,et al. Clostridium difficile toxin A in infants. , 1983, The Journal of infectious diseases.
[32] T. Gray,et al. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. , 1996, Gut.
[33] S. Borriello,et al. Evaluation of the predictive capability of an in-vitro model of colonisation resistance to Clostridium difficile infection , 1988 .
[34] T. Wilkins,et al. Biological activities of toxins A and B of Clostridium difficile , 1982, Infection and immunity.
[35] S. Borriello,et al. Specific binding of nucleotides and NAD+ to Clostridium difficile toxin A , 1992, FEBS letters.
[36] S. Borriello,et al. Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters , 1990, Antimicrobial Agents and Chemotherapy.
[37] M. Wilm,et al. The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins(*) , 1995, The Journal of Biological Chemistry.
[38] R. Guerrant,et al. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro , 1988, Infection and immunity.
[39] S. Borriello,et al. Detection of capsule in strains of Clostridium difficile of varying virulence and toxigenicity. , 1990, Microbial pathogenesis.
[40] R Sedivy,et al. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. , 1995, The Journal of clinical investigation.
[41] Y. Banno,et al. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. , 1984, Reviews of infectious diseases.
[42] B. Werneburg,et al. Clostridium difficile toxin B: characterization and sequence of three peptides. , 1989, Journal of chromatography.
[43] T. Wilkins,et al. Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y , 1991, Infection and immunity.
[44] A. Price,et al. Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. , 1987, Journal of medical microbiology.
[45] K. Saum,et al. Effects of Clostridium difficile toxins given intragastrically to animals , 1985, Infection and immunity.
[46] -. Steffen,et al. Hydrolytic enzymes of anaerobic bacteria isolated from human infections , 1981, Journal of clinical microbiology.
[47] S. Borriello,et al. Antibiotic and pseudomembranous colitis. , 1981, The Journal of antimicrobial chemotherapy.
[48] C L Oakley,et al. Clostridium difficile: isolation and characteristics. , 1976, Journal of medical microbiology.
[49] A. Servin,et al. Identification and characterization of adhesive factors of Clostridium difficile involved in adhesion to human colonic enterocyte‐like Caco‐2 and mucus‐secreting HT29 cells in culture , 1993, Molecular microbiology.
[50] S. Borriello,et al. Evaluation of the proposed interaction of nucleic acid with Clostridium difficile toxins A and B and the effects of nucleases on cytotoxicity. , 1991, FEMS Microbiology Letters.
[51] P. Bourlioux,et al. Cloning of a genetic determinant from Clostridium difficile involved in adherence to tissue culture cells and mucus , 1994, Infection and immunity.
[52] S. Borriello,et al. Detection of fimbriae amongst strains of Clostridium difficile , 1988 .
[53] R. H. Schloemer,et al. Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes , 1987, Infection and immunity.
[54] J. Bartlett,et al. Myoelectric effects of Clostridium difficile: motility-altering factors distinct from its cytotoxin and enterotoxin in rabbits. , 1982, Gastroenterology.
[55] M. Popoff,et al. Survey of neuraminidase production by Clostridium butyricum, Clostridium beijerinckii, and Clostridium difficile strains from clinical and nonclinical sources , 1985, Journal of clinical microbiology.
[56] I. Florin,et al. Polyphosphate-mediated protection from cellular intoxication with Clostridium difficile toxin B. , 1984, Biochimica et biophysica acta.
[57] S. Borriello,et al. An in-vitro model of colonisation resistance to Clostridium difficile infection. , 1986, Journal of medical microbiology.
[58] T. Wilkins,et al. Positive regulation of Clostridium difficile toxins , 1997, Infection and immunity.
[59] S. Donta,et al. Neonatal antibiotic-associated colitis. , 1981, American journal of diseases of children.
[60] L. A. Barroso,et al. Nucleotide sequence of Clostridium difficile toxin B gene , 1990, Nucleic Acids Res..
[61] S. Borriello,et al. Nonspecific Binding of Clostridium difficile Toxin A to Murine Immunoglobulins Occurs via the Fab Component , 1998, Infection and Immunity.
[62] J. Bartlett. Antibiotic-associated pseudomembranous colitis. , 1979, Hospital practice.
[63] M. Giuliano,et al. Production of an enterotoxin different from toxin A by Clostridium difficile , 1988 .
[64] J. Johnson,et al. Transcriptional analysis of the toxigenic element of Clostridium difficile. , 1997, Microbial pathogenesis.
[65] J. Johnson,et al. Molecular characterization of the Clostridium difficile toxin A gene , 1990, Infection and immunity.